Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Additionally, compared to stage 0, participants in stages 2-4b showed a significantly higher serum vitamin D level.

Source: Participants and demographic characteristics. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

The reason why we excluded participants aged below 20 years old instead of 18 years old was that some of the demographic data in the NHANES survey, such as and, was only available among participants above 20 years old to avoid the potential disclosure risks.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Stage-specific associations of mineralization markers with CKM syndrome: Nationwide survey and genetic evidence for Alkaline phosphatase’s unique clinical role

Study design awaiting verification · PLOS One · 2026

Original publication title

Stage-specific associations of mineralization markers with CKM syndrome: Nationwide survey and genetic evidence for Alkaline phosphatase’s unique clinical role

Lei Hua; Yongshou Tao; Liangru Shen

© 2026 Hua et al

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

ALP demonstrates consistent associations with all CKM stages. These findings indicate that ALP-related mechanisms need further exploration.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Cardiovascular-Kidney-Metabolic (CKM) syndrome involves disordered mineralization processes. Herein, we investigated the serum alkaline phosphatase (ALP), calcium, and phosphorus across CKM stages.

Source: Background

Abstract: What methods does the paper describe?

This study analyzed 15,233 eligible participants in National Health and Nutrition Examination Survey (2009 to 2018) using survey-weighted multinomial logistic regression to assess associations of ALP, calcium, and phosphorus. Restricted cubic splines assessed non-linear relationships, while Cox models examined mortality risks. Two-sample Mendelian randomization (MR) explored causal relationships.

Source: Methods

Abstract: Results

Relative risk ratios (RRRs) and 95% confidence intervals (95% CI) were calculated with multinomial logistic regression. Compared with stage 0, ALP was positively associated with the likelihood of being classified into stage 2 (RRR, 1.23[95% CI, 1.11 to 1.37]), stage 3 (RRR, 1.99 [95% CI, 1.48 to 2.67]), stage 4a (RRR, 1.29 [95% CI, 1.14 to 1.46]), stage 4b (RRR, 1.35 [95% CI, 1.16 to 1.58]). Per mg/dL increase in serum calcium levels was associated with a higher likelihood of being classified into stages 2 (RRR = 2.13, 95% CI: 1.55 to 2.94) and CKM stage 4, while per mg/dL increase in serum phosphorus was associated with stage 3 classification (RRR = 2.85, 95% CI: 1.77 to 4.59) and the results remained consistent after standardizing the markers using z-scores.

ALP’s 4th quartile was associated with the highest mortality risks (CKM-cause hazard ratio = 2.20; all-cause hazard ratio = 2.15). MR analysis indicated potential causal effects of ALP on cardiovascular disease and of chronic kidney disease on ALP.

Source: Results

Abstract: Conclusions

ALP demonstrates consistent associations with all CKM stages. These findings indicate that ALP-related mechanisms need further exploration.

Source: Conclusions
Authors’ abstract

Background

Cardiovascular-Kidney-Metabolic (CKM) syndrome involves disordered mineralization processes. Herein, we investigated the serum alkaline phosphatase (ALP), calcium, and phosphorus across CKM stages.

Methods

This study analyzed 15,233 eligible participants in National Health and Nutrition Examination Survey (2009 to 2018) using survey-weighted multinomial logistic regression to assess associations of ALP, calcium, and phosphorus. Restricted cubic splines assessed non-linear relationships, while Cox models examined mortality risks. Two-sample Mendelian randomization (MR) explored causal relationships.

Results

Relative risk ratios (RRRs) and 95% confidence intervals (95% CI) were calculated with multinomial logistic regression. Compared with stage 0, ALP was positively associated with the likelihood of being classified into stage 2 (RRR, 1.23[95% CI, 1.11 to 1.37]), stage 3 (RRR, 1.99 [95% CI, 1.48 to 2.67]), stage 4a (RRR, 1.29 [95% CI, 1.14 to 1.46]), stage 4b (RRR, 1.35 [95% CI, 1.16 to 1.58]). Per mg/dL increase in serum calcium levels was associated with a higher likelihood of being classified into stages 2 (RRR = 2.13, 95% CI: 1.55 to 2.94) and CKM stage 4, while per mg/dL increase in serum phosphorus was associated with stage 3 classification (RRR = 2.85, 95% CI: 1.77 to 4.59) and the results remained consistent after standardizing the markers using z-scores.

ALP’s 4th quartile was associated with the highest mortality risks (CKM-cause hazard ratio = 2.20; all-cause hazard ratio = 2.15). MR analysis indicated potential causal effects of ALP on cardiovascular disease and of chronic kidney disease on ALP.

Conclusions

ALP demonstrates consistent associations with all CKM stages. These findings indicate that ALP-related mechanisms need further exploration.

Publication and source details

Original title: Stage-specific associations of mineralization markers with CKM syndrome: Nationwide survey and genetic evidence for Alkaline phosphatase’s unique clinical role

Lei Hua; Yongshou Tao; Liangru Shen

PLOS One · 2026

Competing Interests: The authors have declared that no competing interests exist.

* E-mail: liangrushenks@163.com
© 2026 Hua et al2026Hua et alhttps://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. http://dx.doi.org/10.13039/501100001809National Natural Science Foundation of China 82300346 https://orcid.org/0009-0001-1109-2305 Shen Liangru Natural Science Foundation of Suqian 2021J296 https://orcid.org/0009-0001-1109-2305 Shen Liangru This study received support from the National Natural Science Foundation of China [grant number 82300346], the Natural Science Foundation of Suqian [Grant Number 2021J296]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T22:17:42.279997+00:00

DOI: 10.1371/journal.pone.0351946 · PMC13278675